HSVTI Formulation 2

N/A

Report date: 2023/08/15 20:01:07

Base Information

Drug NameHSVTI Formulation 2

Drug Alias NameTargeted Immunotherapy Against HSV(Formulation 2)Herpes Simplex Virus (HSV)-Targeted Immunotherapy(HSVTI Formulation 2)HSV-targeted Immunotherapy(HSVTI Formulation 2)

ClassificationVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHerpes Simplex

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc

Inactive CompaniesN/A

Active IndicationsHerpes Simplex

Inactive IndicationsN/A

Other Information

ATC CodeN/A